Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LYL797 |
Trade Name | |
Synonyms | LYL-797|LYL 797 |
Drug Descriptions |
LYL797 is a chimeric antigen receptor T-cell (CAR-T) therapy that targets ROR1, potentially resulting in antitumor activity against ROR1-expressing tumors (Cancer Res (2022) 82 (12_Supplement): 2754). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187118 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LYL797 | LYL797 | 0 | 1 |